{"title":"The Emergence of Qnr-resistance Among Klebsiella pneumoniae spp in Zahedan","authors":"F. Rostami, Saman Shalibeik, S. Shahraki","doi":"10.22034/IJPS.2018.37555","DOIUrl":null,"url":null,"abstract":"Objective: Although quinolone resistance results mostly from chromosomal mutations in Klebsiella pneumoniae, it may also be mediated by plasmid – encoded qnr determinants. Plasmid-mediated quinolone resistance (PMQR) was increasingly identified in Enterobacteriaceae family worldwide. The aim of this study was to investigate the prevalence of qnr genes in clinical isolates of Klebsiella pneumoniae spp in Zahedan, south-East of Iran. Methods: In this sectional-descriptive study which was performed in 2013, clinical isolates of k. pneumoniae (n=184) were collected from patients referred to 3hospitals of Zahedan. The presence of the qnr gene was screened by PCR using specific primers for qnrA, qnrB, qnrS and qnrC in extracted plasmid DNA. Results: of 184 K. pneumoniae clinical isolates, 45 isolates were positive for the qnr gene. The prevalence of qnrA, qnrB and qnrS clusters among these isolates were 8 (17.7%), 22 (48.8%), 4(8.88%) respectively and qnrC was not identified in any isolate. Another 6(13.33%) possessed both qnrA and qnrB genes and 5(11.11%) possessed both qnrB and qnrS. Conclusion: qnr are widely distributed worldwide. Community-acquired and nosocomial pathogens and the emergence of qnr-mediated quinolone resistance among clinical K.pneumoniae isolates are described for the first time in Iran.","PeriodicalId":14582,"journal":{"name":"Iranian Journal of Pharmaceutical Sciences","volume":"14 1","pages":"91-98"},"PeriodicalIF":0.0000,"publicationDate":"2018-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22034/IJPS.2018.37555","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Although quinolone resistance results mostly from chromosomal mutations in Klebsiella pneumoniae, it may also be mediated by plasmid – encoded qnr determinants. Plasmid-mediated quinolone resistance (PMQR) was increasingly identified in Enterobacteriaceae family worldwide. The aim of this study was to investigate the prevalence of qnr genes in clinical isolates of Klebsiella pneumoniae spp in Zahedan, south-East of Iran. Methods: In this sectional-descriptive study which was performed in 2013, clinical isolates of k. pneumoniae (n=184) were collected from patients referred to 3hospitals of Zahedan. The presence of the qnr gene was screened by PCR using specific primers for qnrA, qnrB, qnrS and qnrC in extracted plasmid DNA. Results: of 184 K. pneumoniae clinical isolates, 45 isolates were positive for the qnr gene. The prevalence of qnrA, qnrB and qnrS clusters among these isolates were 8 (17.7%), 22 (48.8%), 4(8.88%) respectively and qnrC was not identified in any isolate. Another 6(13.33%) possessed both qnrA and qnrB genes and 5(11.11%) possessed both qnrB and qnrS. Conclusion: qnr are widely distributed worldwide. Community-acquired and nosocomial pathogens and the emergence of qnr-mediated quinolone resistance among clinical K.pneumoniae isolates are described for the first time in Iran.
期刊介绍:
Iranian Journal of Pharmaceutical Sciences (IJPS) is an open access, internationally peer-reviewed journal that seeks to publish research articles in different pharmaceutical sciences subdivisions: pharmacology and toxicology, nanotechnology, pharmaceutics, natural products, biotechnology, pharmaceutical chemistry, clinical pharmacy and other pharmacy related topics. Each issue of the journal contents 16 outstanding research articles in area of pharmaceutical sciences plus an editorial written by the IJPS editors on one of the most up to date advances topics in pharmacy. All articles published by IJPS would be permanently accessible online freely without any subscription charges. Authors of the published articles have granted the right to use and disseminate their article to third parties.